Quick answer
Source IGF-1 LR3 only with an HPLC trace, mass-spec identity near 9.1 kDa and a COA matching the lot on the vial.
- Why it is harder: an 83-residue engineered analog with three disulfide bonds
- Verify: purity of at least 98% by HPLC with method, mass-spec identity, batch COA, net peptide content
- Form: lyophilized powder, stored at 2–8 °C or −20 °C long term
- V8 listing: IGF-1 LR3, 1 mg vial; see the CoA library
- Concentration: mg ÷ mL; see the calculator
For laboratory research use only; not for human consumption.
What IGF-1 LR3 is, and why sourcing it is different
IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1, engineered with an amino acid substitution and an N-terminal extension that reduce its binding affinity to IGF-binding proteins and extend its circulating half-life relative to native IGF-1 in laboratory models. It is not a naturally occurring human peptide; it is a lab-engineered research variant, which raises the sourcing bar rather than lowering it. A vial labeled "IGF-1 LR3" tells a lab nothing about whether the correct sequence, folding, and purity were actually achieved during synthesis; only independent analytical documentation does that.
The molecule is an 83-residue protein analog, not a short chain. Native IGF-1 has 70 residues and a mass of about 7.65 kDa. In the LR3 analog, glutamate at position 3 is replaced by arginine (the "R3"), and a 13-residue extension is added at the N-terminus (the "long" part), giving an 83-residue chain of about 9.1 kDa. Like native IGF-1 it contains three intramolecular disulfide bonds, which must form correctly for the folded protein to be the intended molecule. The V8 listing gives the formula as C400H625N111O115S9.
| Property | Native IGF-1 | IGF-1 LR3 |
|---|---|---|
| Residues | 70 | 83 |
| Approximate mass | About 7.65 kDa | About 9.1 kDa |
| Position 3 | Glutamate | Arginine |
| N-terminal extension | None | 13 residues |
| Disulfide bonds | 3 | 3 |
| IGFBP affinity | High | Markedly reduced |
What to verify before ordering
For a molecule of this size, a short checklist separates documented material from unsupported claims.
- Purity of at least 98% by HPLC, reported with the chromatography method and column conditions disclosed, not a bare percentage on a label. Background: HPLC purity analysis.
- Mass spectrometry identity confirmation. IGF-1 LR3 is a larger, more structurally complex molecule than most short research peptides, so sequence and mass confirmation matter even more than with simpler peptides. HPLC retention time alone cannot distinguish a correctly folded, full-length analog from a truncated or misfolded synthesis byproduct. See HPLC vs. mass spectrometry.
- Batch-specific Certificate of Analysis, tied to the lot actually shipped, not a template reused across runs. See how to read a COA.
- Lyophilized form and clear handling guidance. IGF-1 LR3's extended structure makes it more sensitive to degradation from improper storage or repeated freeze-thaw than smaller peptides. It should arrive lyophilized, not pre-mixed.
- Disclosed net peptide content. The gross vial weight (for example 1 mg) includes counter-ions and residual moisture from lyophilization; actual peptide mass is lower. A supplier willing to publish net content alongside gross label weight gives labs an honest basis for calculating concentrations.
Why sourcing discipline matters more for this analog
Because IGF-1 LR3 is synthesized rather than naturally derived, small errors in the synthesis or purification process are more consequential than with shorter, simpler peptides. An incomplete sequence or a disulfide-bond mismatch can still register as "IGF-1 LR3" on a basic purity check while being structurally and functionally different from the intended analog in downstream research. That is precisely why mass spectrometry confirmation and a batch-matched COA are not optional extras for this compound; they are the only way a lab can know the material matches the analog described in the literature it is citing.
Mass spectrometry does have limits here. An intact mass near 9.1 kDa confirms that the full-length chain is present and that no large truncation has occurred, but disulfide connectivity (which cysteines pair with which) is not read from intact mass, since misfolded isomers have the same mass. Labs for whom the folded state is critical typically confirm it with a functional receptor-binding or cell-based assay on their own retained sample.
Reading the analytical claims
Claims made on a product page translate into specific documents. The table maps each claim to the evidence a careful buyer would want.
| Claim | Evidence to ask for | Red flag |
|---|---|---|
| Purity of at least 98% | HPLC trace with method, wavelength and integration table | Percentage only, no trace |
| Identity confirmed | Mass spectrum showing observed vs. theoretical mass (about 9.1 kDa) | Statement of "confirmed" with no mass values |
| Batch-specific | Lot number on the certificate matches the vial | Same certificate reused across lots |
| Lyophilized powder | Sealed vial, powder cake, no pre-mixed solution | Liquid product with no stability data |
| Research use only | Consistent labeling on page, vial and paperwork | Usage or administration instructions anywhere |
The same reasoning is applied across compounds in third-party testing explained, and the compound-specific analytical notes are in IGF-1 LR3 purity testing.
Questions worth asking any supplier
- Is the COA generated per production batch, with a lot number that matches what is printed on the vial received?
- Was identity testing performed by mass spectrometry, and is that data available on request?
- Does the supplier disclose the synthesis route and purification steps when asked directly?
- Are storage and handling instructions specific to IGF-1 LR3, or generic text copied across every product page?
- Is sale explicitly restricted to research use, with no administration guidance implying otherwise?
A supplier that can answer these without hedging, and that will produce a batch-specific COA on request, is operating the way a laboratory reagent supplier should. Vague answers or a refusal to provide lot-matched documentation are reasons to source elsewhere. A fuller framework is in the supplier checklist.
Price relative to documentation
IGF-1 LR3 is more expensive to synthesize correctly than most shorter research peptides because of its length and the additional purification steps needed to reach high purity at that size. Pricing that undercuts the market significantly while still claiming at least 98% HPLC purity and mass-spec-confirmed identity is worth scrutinizing; at minimum, ask to see the actual batch COA before assuming the claim is accurate. Cost per milligram is also a poor comparison unless net peptide content is known, because a vial with more counter-ion and water delivers less peptide at the same label weight.
Receiving and handling a vial
Check on arrival that the vial is sealed, the lyophilized cake is intact, and the lot number matches the paperwork. The product page lists storage at 2–8 °C, with −20 °C for long-term storage, protected from heat, moisture and light. Let the vial reach room temperature before opening, record the date, and plan any reconstitution as laboratory concentration math: labeled mass divided by diluent volume gives mg/mL, which the peptide calculator computes. Because this is a 1 mg vial, small volumes matter; a 1 mg vial in 1 mL is a nominal 1 mg/mL stock (about 0.11 mM at roughly 9.1 kDa). Procedure and general stability notes are in storing research peptides and how to reconstitute a lyophilized peptide.
Choosing between forms is a separate question; the IGF-1 LR3 vs. IGF-1 DES comparison covers it, and IGF-1 LR3 explained gives general background.
Where to buy documented IGF-1 LR3
V8 Peptides supplies IGF-1 LR3 as a 1 mg lyophilized powder with a listed HPLC purity of at least 98%, a batch-specific Certificate of Analysis published on the site, and fulfillment by USPS. The vial is on the IGF-1 LR3 research vial product page, which states that the sequence is reported on the certificate where published and shows whether a given lot's certificate is complete or still in progress; read that status before ordering. Lot documents are collected in the CoA library. For background on the analog's structure and binding behavior, see the IGF-1 LR3 research overview.
Where to Buy IGF-1 LR3 FAQ
What should an IGF-1 LR3 certificate show?
A lot number matching the vial, an HPLC trace with method and purity, and a mass spectrum with observed and theoretical masses near 9.1 kDa, plus test date and laboratory.
Why is mass spectrometry especially important for IGF-1 LR3?
Because it is an 83-residue protein analog, truncated or modified chains are more likely and are not reliably separated from the full-length product by retention time alone.
Can mass spectrometry confirm correct disulfide folding?
Not from intact mass, since misfolded isomers have the same mass. Folding is usually checked with a functional assay on a retained sample.
What does gross versus net peptide content mean?
Gross is the labeled powder mass in the vial; net is the peptide mass after subtracting counter-ions and water. Concentrations calculated from gross mass overstate the real peptide amount.
Why does IGF-1 LR3 behave differently from native IGF-1 in models?
The Arg3 substitution and N-terminal extension reduce binding to IGF-binding proteins, so more of the analog remains free to interact with the receptor in culture systems.
Is a low price a concern?
It is worth checking. Correct synthesis and purification of an 83-residue analog is costly, so ask for the batch COA and mass data before assuming the claim holds.
Does V8 Peptides publish the certificate for every IGF-1 LR3 lot?
The product page shows the certificate status for the current lot, including whether it is still in progress. Check it and the CoA library before ordering.
How should the vial be stored?
As lyophilized powder at 2–8 °C, or −20 °C for long-term storage, protected from heat, moisture and light, per the product page.
Research Use Only. For laboratory research use only; not for human consumption. This article is research education, not usage guidance.
